Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
14651000188113 | védolizumab | fr | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT Common French translation module (core metadata concept) |
3522693013 | Product containing vedolizumab (medicinal product) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
3716978011 | Vedolizumab-containing product | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
735381000241113 | védolizumab (produit médicinal) | fr | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT Common French translation module (core metadata concept) |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
védolizumab | est un(e) (attribut) | Product containing immunomodulator (product) | true | Inferred relationship | Some | ||
védolizumab | est un(e) (attribut) | Product containing monoclonal antibody (product) | true | Inferred relationship | Some | ||
védolizumab | est un(e) (attribut) | Inflammatory bowel disease drug (product) | false | Inferred relationship | Some | ||
védolizumab | est un(e) (attribut) | Product containing alpha-4 integrin receptor antagonist (product) | true | Inferred relationship | Some | ||
védolizumab | a pour principe actif (attribut) | Vedolizumab | true | Inferred relationship | Some | 1 |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Product containing only vedolizumab (medicinal product) | est un(e) (attribut) | True | védolizumab | Inferred relationship | Some | |
Vedolizumab-containing product in parenteral dose form | est un(e) (attribut) | True | védolizumab | Inferred relationship | Some | |
Product containing precisely vedolizumab 300 milligram/1 vial powder for conventional release solution for injection (clinical drug) | est un(e) (attribut) | False | védolizumab | Inferred relationship | Some |
This concept is not in any reference sets